-Cancer Outcomes (CO) Shared Resource The Cancer Outcomes (CO) Shared Resource is a new resource to support a large and highly productive group of cancer center faculty conducting population science big data research, including analyses of linked cancer registry/insurance claims datasets; epidemiologic cohort studies; registries; and other real-world clinical data sources. The CO provides three main services: 1) development and support of a North Carolina multi- payer linked dataset; 2) methodological consulting services for population science big data analyses; and 3) software/systems development for managing real-world clinical data. By collaborating with the North Carolina Central Cancer Registry and other data partners, this unique North Carolina dataset represents the entire state?s cancer population (>400,000 patients) as well as 5.5 million unique beneficiaries in Medicare, Medicaid, and private insurance plans. This rich and unprecedented state-level resource represents heterogeneous populations which are often not represented in clinical trials. This shared resource directly addresses the emerging need of population science to develop big data infrastructure and methods. Research supported by the CO can directly answer crucial questions in cancer care related to access, disparities, quality, technology diffusion, guideline adherence, and cost of cancer care. The differential impact of insurance coverage models and policy initiatives can also be evaluated at the population, provider, and patient levels. Through an interdisciplinary ?team science? approach, the Cancer Outcomes Shared Resource has developed novel data linkages, systems, and methods that allow researchers to better leverage the power of big data to improve population health. By partnering closely with computer scientists and research methodologists the CO team has developed extensive tools and web systems which make these big datasets interoperable and support the entire research lifecycle from hypothesis generation through manuscript publication. Supported by Cancer Center funds since its inception in 2012, this shared resource is already a highly used and successful resource: CO staff has worked with 36 faculty members, enabled publication of 41 manuscripts in peer- reviewed journals and nearly $10 million in funding from private and public sources external to UNC. Funds are proposed to support salary for key staff members and annual data updates

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-43
Application #
9614914
Study Section
Subcommittee I - Career Development (NCI)
Project Start
Project End
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
43
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Wang, Gary P; Terrault, Norah; Reeves, Jacqueline D et al. (2018) Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection. Sci Rep 8:3199
Phillips, Bonnie; Van Rompay, Koen K A; Rodriguez-Nieves, Jennifer et al. (2018) Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques. J Virol 92:
Lianga, Noel; Doré, Carole; Kennedy, Erin K et al. (2018) Cdk1 phosphorylation of Esp1/Separase functions with PP2A and Slk19 to regulate pericentric Cohesin and anaphase onset. PLoS Genet 14:e1007029
Allott, Emma H; Geradts, Joseph; Cohen, Stephanie M et al. (2018) Frequency of breast cancer subtypes among African American women in the AMBER consortium. Breast Cancer Res 20:12
Dhungel, Bal Mukunda; Montgomery, Nathan D; Painschab, Matthew S et al. (2018) 'Discovering' primary effusion lymphoma in Malawi. AIDS 32:2264-2266
Cameron, Jennifer E; Rositch, Anne F; Vielot, Nadja A et al. (2018) Epstein-Barr Virus, High-Risk Human Papillomavirus and Abnormal Cervical Cytology in a Prospective Cohort of African Female Sex Workers. Sex Transm Dis 45:666-672
Lim, Joseph K; Liapakis, Ann Marie; Shiffman, Mitchell L et al. (2018) Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis. Clin Gastroenterol Hepatol 16:1811-1819.e4
Dronamraju, Raghuvar; Jha, Deepak Kumar; Eser, Umut et al. (2018) Set2 methyltransferase facilitates cell cycle progression by maintaining transcriptional fidelity. Nucleic Acids Res 46:1331-1344
Koehler, Jennifer W; Miller, Andrew D; Miller, C Ryan et al. (2018) A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma. J Neuropathol Exp Neurol 77:1039-1054
Takaku, Motoki; Grimm, Sara A; Roberts, John D et al. (2018) GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network. Nat Commun 9:1059

Showing the most recent 10 out of 1525 publications